The molybdenum-containing enzyme sulfite oxidase catalyzes the convers
ion of sulfite to sulfate, the terminal step in the oxidative degradat
ion of cysteine and methionine. Deficiency of this enzyme in humans us
ually leads to major neurological abnormalities and early death. The c
rystal structure of chicken liver sulfite oxidase at 1.9 Angstrom reso
lution reveals that each monomer of the dimeric enzyme consists of thr
ee domains. At the active site, the Mo is penta-coordinated by three s
ulfur ligands, one oxo group, and one water/hydroxo. A sulfate molecul
e adjacent to the Mo identifies the substrate binding pocket. Four var
iants associated with sulfite oxidase deficiency have been identified:
two mutations are near the sulfate binding site, while the other muta
tions occur within the domain mediating dimerization.